Lipopolysaccharide

Lore & Background

The toxic activity of LPS was first discovered and termed endotoxin by Richard Friedrich Johannes Pfeiffer, who distinguished between exotoxins and endotoxins—toxins 'within' the bacterial cell released only after destruction of the bacterial outer membrane. Subsequent work showed that release of LPS does not necessarily require destruction of the cell wall; LPS is also secreted as part of normal physiological activity via bacterial outer membrane vesicles (OMVs). LPS is a major component of the outer cell membrane of Gram-negative bacteria, contributing greatly to structural integrity and protecting the membrane from chemical attack. It is the most abundant antigen on the cell surface of most Gram-negative bacteria, constituting about 75% of the outer leaflet of the outer membrane of E. coli and Salmonella. LPS increases the negative charge of the cell membrane and helps stabilize overall membrane structure. It is of crucial importance to many Gram-negative bacteria, which die if the genes coding for it are mutated or removed, though it appears nonessential in some species such as Neisseria meningitidis, Moraxella catarrhalis, and Acinetobacter baumannii. The composition of LPS is amphipathic: the O-antigen is a repetitive glycan polymer that determines serological specificity, the core oligosaccharide is less variable and contains sugars such as heptose and KDO, and lipid A is a phosphorylated glucosamine disaccharide with fatty acids that anchors LPS into the membrane. The lipid A domain is the most bioactive and responsible for much of the toxicity. A highly conserved host enzyme, acyloxyacyl hydrolase (AOAH), can detoxify LPS by removing secondary acyl chains; dephosphorylation by intestinal alkaline phosphatase can also reduce severity of certain infections.

Reader's Guide

Lipopolysaccharide is of central significance in microbiology and medicine as the primary endotoxin of Gram-negative bacteria. Its discovery by Richard Pfeiffer established the foundational distinction between exotoxins and endotoxins. LPS is a key structural component of the Gram-negative outer membrane, contributing up to 80% of the outer membrane in E. coli and Salmonella, and is essential for the survival of many such bacteria. Its three-part structure—O-antigen, core oligosaccharide, and lipid A—determines serological specificity, membrane integrity, and toxicity. The lipid A moiety is the most bioactive, responsible for fever, diarrhea, and potentially fatal endotoxic septic shock. LPS is a potent activator of the immune system and a pyrogen; chronic low-level exposure may contribute to autoimmunity, obesity, depression, and cellular senescence. The host enzyme acyloxyacyl hydrolase (AOAH) can detoxify LPS, and intestinal alkaline phosphatase can reduce infection severity. LPS is also involved in bacterial ecology, including surface adhesion and bacteriophage sensitivity. Its transport system, involving Lpt proteins, represents a potential antibiotic target. The rough form of LPS, lacking O-antigen, is termed lipooligosaccharide (LOS) and is found in some bacteria, playing roles in pathogenesis and immune evasion.

Did You Know?

• LPS constitutes about 75% of the outer leaflet of the outer membrane of E. coli and Salmonella.
• The lipid A domain is the most bioactive part of LPS and is responsible for much of its toxicity.
• A host enzyme called acyloxyacyl hydrolase (AOAH) can detoxify LPS by removing two secondary acyl chains from lipid A.
• The rough form of LPS, lacking O-antigen, is called lipooligosaccharide (LOS) and is found in Neisseria spp., Haemophilus spp., and Akkermansia spp.

Molecular Architecture: Three Domains in One Molecule

Lipopolysaccharide is an amphipathic macromolecule built from three covalently linked domains, each with a distinct chemical character. The outermost region is the O-antigen, a hydrophilic repetitive glycan polymer whose structure varies enormously between strains—E. When a full-length O-chain is present the molecule is described as smooth; its absence or truncation yields a rough form that renders the cell membrane more permeable to hydrophobic antibiotics. Beneath the O-antigen sits the core oligosaccharide, also hydrophilic but far less variable, typically incorporating sugars such as heptose and KDO (3-deoxy-D-manno-oct-2-ulosonic acid) along with phosphate, amino-acid, and ethanolamine substituents. The innermost domain, lipid A, is a phosphorylated glucosamine disaccharide decorated with multiple hydrophobic fatty-acid chains that anchor the entire structure into the bacterial membrane. Although lipid A is the most conserved region, its precise fatty-acid pattern differs among species and largely dictates the strength and character of the host immune response it provokes.

Structural Guardian of the Gram-Negative Cell

For the vast majority of Gram-negative organisms, lipopolysaccharide is not merely a surface decoration but a load-bearing component of the outer membrane. In well-studied species such as E. coli and Salmonella, LPS can account for as much as eighty percent of the total outer-membrane mass, making it the single most abundant antigen presented on the bacterial surface. The molecule increases the overall negative charge of the membrane and helps stabilize its architecture, while also shielding the cell from certain chemical assaults. For many Gram-negative bacteria the cost of losing LPS is fatal: mutating or deleting the genes responsible for its synthesis kills the organism. Yet the picture is not universal—Neisseria meningitidis, Moraxella catarrhalis, and Acinetobacter baumannii appear to survive without it, and some of these species instead carry a shorter lipooligosaccharide that fulfils a similar structural role. Beyond basic survival, LPS participates in surface adhesion, modulates sensitivity to bacteriophage infection, shapes interactions with predatory amoebae, and is essential for the activity of omptins, a family of bacterial proteases.

From Fever to Failure: LPS and the Human Immune System

The clinical significance of lipopolysaccharide lies almost entirely in its capacity to activate the host immune system. Lipid A, the hydrophobic anchor of the molecule, is the principal toxic moiety; when immune cells lyse Gram-negative bacteria, fragments of membrane bearing lipid A spill into the bloodstream and trigger a cascade that can produce fever, diarrhea, and, in severe cases, a rapid and overwhelming inflammatory response culminating in multi-organ failure and endotoxic septic shock. The precise structure of lipid A—its fatty-acid chain length and number—largely determines how strongly and in what manner the immune system is engaged. At lower concentrations sustained over months or years, circulating LPS has been implicated in a broader spectrum of chronic pathology, including autoimmune disorders, obesity, depression, and accelerated cellular senescence. In the rough-form lipooligosaccharide found in Neisseria, Haemophilus, and Akkermansia species, the molecule additionally acts as an immunostimulator and immunomodulator, and some strains exploit its structural plasticity for molecular mimicry and antigenic diversity, helping them evade host antibody recognition.

Pfeiffer's Endotoxin and the Vesicle Revelation

The toxic properties of what we now call LPS were first recognized by Richard Friedrich Johannes Pfeiffer, who coined the term endotoxin to describe a class of bacterial poisons that reside inside the cell and are liberated only after the bacterial outer membrane is destroyed. He drew a clear distinction between these intracellular toxins and exotoxins, which bacteria actively secrete into their surroundings. For decades the prevailing view held that LPS release required complete cell lysis. Later research complicated this picture by showing that Gram-negative bacteria routinely shed LPS through a physiological process called outer membrane vesicle trafficking; these nanoscale vesicles carry LPS along with other virulence factors and proteins into the extracellular environment without the parent cell needing to die. It is also worth noting that the word endotoxin is not synonymous with LPS in every context: certain delta-endotoxin proteins produced by Bacillus thuringiensis fall under the original definition of intracellular toxins but are structurally unrelated to lipopolysaccharide. Today the two terms are used interchangeably in most clinical and research literature, though the historical distinction remains important for precise communication.